GUIDED THERAPEUTICS INC | Business Contracts

Amendment #1 to Exchange Agreement between the Company and Auctus Fund, LLC (Filed With SEC on November 14, 2022)

Form of Warrants issued to Auctus Fund, LLC (Filed With SEC on September 15, 2022)

Consulting Agreement with Richard Blumberg, dated as of March 11, 2021 (Filed With SEC on April 7, 2021)

Lease Modification, dated as of February 23, 2018, by and between Guided Therapeutics, Inc. and TREA Infill Industrial Atlanta, LLC (Filed With SEC on April 20, 2020)

License Agreement Modification, dated as of July 24, 2019, by and between Guided Therapeutics, Inc. and Shandong Medical Instrument Corporation (Filed With SEC on April 20, 2020)

Form of Warrants issued to Auctus Fund, LLC (Filed With SEC on September 15, 2022)

Exchange Agreement between the Company and Auctus Fund, LLC (Filed With SEC on September 15, 2022)

Form Securities Purchase Agreement (Filed With SEC on September 15, 2022)

Form of Warrant (Filed With SEC on September 15, 2022)

Form of Public Warrant (Filed With SEC on July 13, 2022)

Form of Underwriting Agreement (Filed With SEC on June 30, 2022)

Form of Warrant Agency Agreement (Filed With SEC on June 30, 2022)

EXCHANGE AGREEMENT (Filed With SEC on June 30, 2022)

Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and Gene S. Cartwright (Filed With SEC on March 30, 2022)

Form of Common Stock Purchase Warrant (Aspen Capital) dated May 31, 2021 (Filed With SEC on March 30, 2022)

Form of Common Stock Purchase Warrant (Iron Stone Capital) dated August 10, 2021 (Filed With SEC on March 30, 2022)

Form of Common Stock Purchase Warrant dated November 4, 2021 (Filed With SEC on March 30, 2022)

Agreement dated September 30, 2021, by and between Guided Therapeutics, Inc. and Richard P. Blumberg (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and John Gould (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 13, 2021, by and between Guided Therapeutics, Inc. and Frederick Grimm (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 16, 2021, by and between Guided Therapeutics, Inc. and Richard P. Blumberg, Esq (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 16, 2021, by and between Guided Therapeutics, Inc. and K2 Medical, LLC (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 10, 2021, by and between Guided Therapeutics, Inc. and John Imhoff, M.D (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and Mark L. Faupel (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and GPB Debt Holdings II LLC (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and Michael C. James (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 30, 2021, by and between Guided Therapeutics, Inc. and Bryan Mamula (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and Flynn D. Case Living Trust (Filed With SEC on March 30, 2022)

Exchange Agreement, dated as of December 30, 2021, by and between Guided Therapeutics, Inc. and Dolores Maloof (Filed With SEC on March 30, 2022)

Promissory Note, dated December 31, 2021, by and between Guided Therapeutics, Inc. and William Wells (Filed With SEC on March 30, 2022)

EXCHANGE AGREEMENT (Filed With SEC on March 30, 2022)

Exchange Agreement dated February 1, 2022, by and between Guided Therapeutics, Inc. and Auctus Fund LLC (Filed With SEC on March 30, 2022)

Form of Pre-Funded Warrant (Filed With SEC on February 17, 2022)

Form of Underwriting Agreement (Filed With SEC on February 17, 2022)

Form of Public Warrant (Filed With SEC on February 17, 2022)

Exchange Agreement, dated as of June 23, 2020, by and between Guided Therapeutics, Inc. and James Clavijo (Filed With SEC on February 17, 2022)

Amendment to the Agreement by and between Guided Therapeutics Inc. and Shandong Yaohua Medical Instrument Corporation, dated August 12, 2021 (Filed With SEC on September 7, 2021)

Form of Acknowledgement (Filed With SEC on June 10, 2021)

Securities Purchase Agreement with Auctus, dated as of May 27, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (Manju Venugopal), dated August 10, 2020 (Filed With SEC on April 7, 2021)

Note Payable Agreement with Gene Cartwright, dated February 19, 2021 (Filed With SEC on April 7, 2021)

Note Payable Agreement with Mark Faupel, dated February 19, 2021 (Filed With SEC on April 7, 2021)

Form of Warrant (Aspen Capital), dated June 23, 2020 (Filed With SEC on April 7, 2021)

Finders Fee Agreement with JH Darbie, dated as of May 19, 2020 (Filed With SEC on April 7, 2021)

Debt for Equity Exchange Agreement with Auctus, dated as of May 22, 2020 (Filed With SEC on April 7, 2021)

Securities Purchase Agreement (Series F), dated March 31, 2020 (Filed With SEC on April 7, 2021)

Finders Fee Agreement with FCMI, dated as of June 11, 2020 (Filed With SEC on April 7, 2021)

Exchange Agreement with William Wells, dated as of July 9, 2020 (Filed With SEC on April 7, 2021)

Securities Purchase Agreement with PowerUp, dated as of December 24, 2020 (Filed With SEC on April 7, 2021)

Securities Purchase Agreement with PowerUp, dated as of February 10, 2021 (Filed With SEC on April 7, 2021)

Exchange Agreement with Richard Fowler, dated as of March 22, 2021 (Filed With SEC on April 7, 2021)

Securities Purchase Agreement (Series E), dated June 30, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (Credential Qtrade Securities Inc. ITF Reve Royalty Income Growth, dated as of June 23, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (James Clavijo), dated June 23, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (Auctus Note), dated May 22, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (Series D Preferred Stock) (Filed With SEC on April 7, 2021)

Form of Warrant (Auctus Note), dated March 31, 2020 (Filed With SEC on April 7, 2021)

Convertible Promissory Note with Auctus, dated March 31, 2020 (Filed With SEC on April 7, 2021)

Form of Warrant (Ironstone Capital), dated April 23, 2020 (Filed With SEC on April 7, 2021)

Common Stock Warrant, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of April 30, 2018, by and between Guided Therapeutics, Inc. and Power Up (Filed With SEC on April 20, 2020)

Purchase and Sale Agreement, dated as of February 14, 2019, by and between Guided Therapeutics, Inc. and Everest Business Funding (Filed With SEC on April 20, 2020)

Equity Financing Agreement, dated as of March 1, 2018, by and between Guided Therapeutics, Inc. and GHS Investments, Inc (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Cartwright (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Faupel (Filed With SEC on April 20, 2020)

Promissory Note, dated as of September 19, 2018, by and between Guided Therapeutics, Inc. and Mr. Gould (Filed With SEC on April 20, 2020)

Promissory Note, dated as of August 22, 2018, by and between Guided Therapeutics, Inc. and Mr. Case (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of July 3, 2018, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of June 22, 2018, by and between Guided Therapeutics, Inc. and GHS Investments, Inc (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of June 7, 2018, by and between Guided Therapeutics, Inc. and Power Up (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of March 12, 2018, by and between Guided Therapeutics, Inc. and Eagle Equities, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of March 20, 2018, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of May 17, 2018, by and between Guided Therapeutics, Inc. and GHS Investments, Inc (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of March 29, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of February 22, 2018, by and between Guided Therapeutics, Inc. and Power Up (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of February 12, 2018, by and between Guided Therapeutics, Inc. and Adar Bays, LLC (Filed With SEC on April 20, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on April 20, 2020)

Form of Warrant (Exchange Agreements) (Filed With SEC on April 20, 2020)

Form of 12% debenture (Filed With SEC on April 20, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on April 20, 2020)

Promissory Note, dated as of February 15, 2019, by and between Guided Therapeutics, Inc. and Mr. Gould (Filed With SEC on April 20, 2020)

Loan Agreement, dated as of July 1, 2019, by and between Guided Therapeutics, Inc. and Accilent Capital Management Inc. / Rev Royalty Trust Income and Growth Trust (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of May 15, 2019, by and between Guided Therapeutics, Inc. and Eagle Equities, LLC (Filed With SEC on April 20, 2020)

Form of Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and Investors (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of March 31, 2020, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Promotional Agreement, dated as of January 22, 2020, by and between Guided Therapeutics, Inc. and Blumberg & Bowles Consulting, LLC (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of January 16, 2020, by and between Guided Therapeutics, Inc. and GPB Debt Holdings II, LLC (Filed With SEC on April 20, 2020)

Promissory Note, dated as of January 15, 2020, by and between Guided Therapeutics, Inc. and IRTH Communications, LLC (Filed With SEC on April 20, 2020)

Finders Fee Agreement, dated as of January 6, 2020, by and between Guided Therapeutics, Inc. and Iron Stone Capital (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and Dr. Imhoff (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of January 6, 2020, by and between Guided Therapeutics, Inc. and Jones Day Law Firm (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and Mr. Blumberg (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and K2 (Filed With SEC on April 20, 2020)

Form of Joinder Agreement (Series D), dated December 30, 2019 (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of May 15, 2019, by and between Guided Therapeutics, Inc. and Adar Bays, LLC (Filed With SEC on April 20, 2020)

Registration Rights Agreement (Series D), dated December 30, 2019 (Filed With SEC on April 20, 2020)

Form of Security Agreement between the Guided Therapeutics, Inc. and investors set forth therein (Filed With SEC on April 20, 2020)

Form of Securities Purchase Agreement between the Guided Therapeutics, Inc. and investors set forth therein (Filed With SEC on April 20, 2020)

Registration Rights Agreement, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Security Agreement, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Securities Purchase Agreement, dated as of December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

Exchange Agreement, dated as of December 5, 2019, by and between Guided Therapeutics, Inc. and Aquarius (Filed With SEC on April 20, 2020)

Addendum to the Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Cartwright (Filed With SEC on April 20, 2020)

Addendum to the Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Faupel (Filed With SEC on April 20, 2020)

Senior Secured Convertible Note, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)

GUIDED THERAPEUTICS INC (108)